Analyst downgrades: PG, HGSI and MT
Posted Apr 17th 2008 11:07AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Procter and Gamble (PG), Zoltek Co (ZOLT)
MOST NOTEWORTHY: Procter & Gamble, Human Genome and Arcelor Mittal were today's noteworthy downgrades:
- Deutsche Bank downgraded shares of Procter & Gamble (NYSE:PG) to Hold from Buy on valuation and their expectation for slowing short-term industry growth, especially in beauty.
- Citigroup downgraded Human Genome (NASDAQ:HGSI) to Hold from Buy as they believe giving up Syncria's royalties removes an important value driver for the stock.
- HSBC downgraded shares of Arcelor Mittal (NYSE:MT) to Neutral from Overweight on valuation and believes the company needs to raise prices more than costs have risen for iron ore, coking coal and steel scrap.
OTHER DOWNGRADES:
Tags: analyst, arcelor mittal, ArcelorMittal, bae systems, baesy, BaeSystems, downgrade, hgsi, human genome, HumanGenome, illinois tool works, IllinoisToolWorks, inthenews, itw, mt, pg, procter gamble, ProcterGamble, zolt, zoltek